Champions Oncology (CSBR) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to -$8.5 million.
- Champions Oncology's Enterprise Value fell 20700.8% to -$8.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$8.5 million, marking a year-over-year decrease of 20700.8%. This contributed to the annual value of -$9.8 million for FY2025, which is 27375.86% down from last year.
- According to the latest figures from Q4 2025, Champions Oncology's Enterprise Value is -$8.5 million, which was down 20700.8% from -$10.3 million recorded in Q3 2025.
- Over the past 5 years, Champions Oncology's Enterprise Value peaked at -$2.6 million during Q2 2024, and registered a low of -$11.6 million during Q1 2023.
- Its 5-year average for Enterprise Value is -$6.7 million, with a median of -$6.5 million in 2021.
- As far as peak fluctuations go, Champions Oncology's Enterprise Value skyrocketed by 7412.53% in 2024, and later crashed by 27375.86% in 2025.
- Champions Oncology's Enterprise Value (Quarter) stood at -$4.8 million in 2021, then crashed by 125.54% to -$10.8 million in 2022, then skyrocketed by 49.08% to -$5.5 million in 2023, then soared by 50.05% to -$2.8 million in 2024, then crashed by 207.01% to -$8.5 million in 2025.
- Its last three reported values are -$8.5 million in Q4 2025, -$10.3 million for Q3 2025, and -$9.8 million during Q2 2025.